The National Institute on Drug Abuse (NIDA) is offering this grant to accelerate the development of medications for the treatment of Substance-Related Disorders (SRDs). This funding opportunity, a U01 cooperative agreement, is designed to support a diverse array of preclinical and/or clinical research projects. The grant is for quickly yielding high-impact results to advance promising medications closer to FDA approval. Projects are expected to be short-term, funded for up to three years, with substantial financial support of up to $5 million annually. NIDA staff will provide close monitoring and significant scientific involvement, enabling critical medication development studies not feasible through traditional mechanisms.
Opportunity ID: 69835
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-11-109 |
Funding Opportunity Title: | Grand Opportunity in Medications Development for Substance-Related Disorders (U01) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Feb 09, 2011 |
Last Updated Date: | – |
Original Closing Date for Applications: | Aug 14, 2013 |
Current Closing Date for Applications: | Aug 14, 2013 |
Archive Date: | Sep 14, 2013 |
Estimated Total Program Funding: | $15,000,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education County governments Small businesses Independent school districts Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Private institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments For profit organizations other than small businesses City or township governments |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the development of medication for the treatment of Substance-Related Disorders (SRDs) by soliciting research applications to support a diverse array of preclinical and/or clinical research projects. The goal is to fund medication studies that will have high impact and quickly yield the necessary results to advance medications closer to FDA approval. It is expected that these U01s will be short-term (funded for up to 3 years) and large (up to $5 million per year) cooperative agreements with close monitoring and significant scientific involvement of NIDA staff. This funding mechanism will enable critical medications development studies that would not be feasible using the traditional R01 mechanism. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-11-109.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
93.279 | ADOBE-FORMS-B1 | ADOBE-FORMS-B1 | PKG00032150 | Apr 26, 2011 | Aug 14, 2013 | View |
Package 1
Mandatory forms
69835 RR_SF424_1_2-1.2.pdf
69835 RR_OtherProjectInfo_1_3-1.3.pdf
69835 RR_KeyPersonExpanded_1_2-1.2.pdf
69835 PerformanceSite_1_4-1.4.pdf
69835 PHS398_ResearchPlan_1_3-1.3.pdf
69835 PHS398_CoverPageSupplement_1_4-1.4.pdf
69835 PHS398_Checklist_1_3-1.3.pdf
Optional forms
69835 RR_Budget-1.1.pdf
69835 RR_SubawardBudget-1.2.pdf
69835 PHS_CoverLetter_1_2-1.2.pdf
69835 PHS398_ModularBudget-1.1.pdf